196 related articles for article (PubMed ID: 8454792)
1. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
[TBL] [Abstract][Full Text] [Related]
2. Spirometry, bronchodilator test or symptom scoring for the assessment of childhood asthma.
Linna O
Acta Paediatr; 1996 May; 85(5):564-9. PubMed ID: 8827100
[TBL] [Abstract][Full Text] [Related]
3. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission.
Boulet LP; Turcotte H; Brochu A
Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720
[TBL] [Abstract][Full Text] [Related]
4. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
Bheekie A; Syce JA; Weinberg EG
J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of peak expiratory flow rate for diagnosing bronchial obstruction on methacholine inhalation challenge in school-aged asthmatic children.
Linna O
Acta Paediatr; 1998 Jun; 87(6):635-7. PubMed ID: 9686655
[TBL] [Abstract][Full Text] [Related]
6. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma.
Goldstein MF; Veza BA; Dunsky EH; Dvorin DJ; Belecanech GA; Haralabatos IC
Chest; 2001 Apr; 119(4):1001-10. PubMed ID: 11296161
[TBL] [Abstract][Full Text] [Related]
8. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge.
Perrin B; Lagier F; L'Archevêque J; Cartier A; Boulet LP; Côté J; Malo JL
Eur Respir J; 1992 Jan; 5(1):40-8. PubMed ID: 1577147
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma.
Côté J; Kennedy S; Chan-Yeung M
J Allergy Clin Immunol; 1990 Mar; 85(3):592-8. PubMed ID: 2179365
[TBL] [Abstract][Full Text] [Related]
10. Twice-daily peak expiratory flow rate monitoring for the assessment of childhood asthma.
Linna OV
Allergy Proc; 1993; 14(1):33-6. PubMed ID: 8462860
[TBL] [Abstract][Full Text] [Related]
11. Effect of alterations of dietary sodium on the severity of asthma in men.
Carey OJ; Locke C; Cookson JB
Thorax; 1993 Jul; 48(7):714-8. PubMed ID: 8153919
[TBL] [Abstract][Full Text] [Related]
12. Effects of inactivated influenza virus vaccination on bronchial reactivity symptom scores and peak expiratory flow variability in patients with asthma.
Sener M; Gürsel G; Türktaş H
J Asthma; 1999; 36(2):165-9. PubMed ID: 10227267
[TBL] [Abstract][Full Text] [Related]
13. Assessment of peak expiratory flow in asthma.
Malo JL
Curr Opin Pulm Med; 1996 Jan; 2(1):75-80. PubMed ID: 9363118
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
15. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period.
Verschelden P; Cartier A; L'Archevêque J; Trudeau C; Malo JL
Eur Respir J; 1996 May; 9(5):880-5. PubMed ID: 8793446
[TBL] [Abstract][Full Text] [Related]
16. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma.
Gagnon M; Côte J; Milot J; Turcotte H; Boulet LP
Chest; 1994 Jun; 105(6):1732-7. PubMed ID: 8205868
[TBL] [Abstract][Full Text] [Related]
17. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile.
Boulet LP; Deschesnes F; Turcotte H; Gignac F
J Allergy Clin Immunol; 1991 Dec; 88(6):838-46. PubMed ID: 1744354
[TBL] [Abstract][Full Text] [Related]
18. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
[TBL] [Abstract][Full Text] [Related]
19. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic.
Gautrin D; D'Aquino LC; Gagnon G; Malo JL; Cartier A
Chest; 1994 Nov; 106(5):1419-26. PubMed ID: 7956394
[TBL] [Abstract][Full Text] [Related]
20. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
